EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enfortumab Vedotin‐Related Skin Toxicities: Insights From Clinical and Histopathological Analysis

Yuki Kuma iD, Makiko Kido-Nakahara iD, Yoko Kuba-Fuyuno iD, Takashi Matsumoto, Yoshinao Oda iD, Masatoshi Eto iD, Takeshi Nakahara iD

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Yuki Kuma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Immune Checkpoint Inhibitors, Drug Eruptions, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enfortumab vedotin (EV), targeting Nectin‐4, is effective in advanced urothelial carcinoma but frequently causes skin toxicities. This study examined the possible contribution of prior immune checkpoint inhibitor (ICI) therapy and higher EV doses to EV‐related skin toxicity (EVST) development. Histopathological findings suggested both direct keratinocyte damage and immune‐mediated mechanisms. These insights may improve clinical management of EVST.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalImmune Checkpoint InhibitorsDrug EruptionsUrinary Bladder NeoplasmsHumansSkinMaleFemaleKeratinocytesAgedMiddle AgedCell Adhesion Molecules

Stichwörter der Autor:innen

Enfortumab vedotinimmune checkpoint inhibitorsskin toxicityurothelial carcinomaantibody‐drug conjugate

Substanzen

Antibodies, Monoclonalenfortumab vedotinImmune Checkpoint InhibitorsCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

ORCID-Profile: Yuki Kuma, Makiko Kido-Nakahara, Yoko Kuba-Fuyuno, Yoshinao Oda, Masatoshi Eto, Takeshi Nakahara

Zitieren

APA

Kuma, Y., Kido-Nakahara, M., Kuba-Fuyuno, Y., Matsumoto, T., Oda, Y., Eto, M., & Nakahara, T. (2025). Enfortumab Vedotin‐Related Skin Toxicities: Insights From Clinical and Histopathological Analysis. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17901

Vancouver

Kuma Y, Kido-Nakahara M, Kuba-Fuyuno Y, Matsumoto T, Oda Y, Eto M, et al. Enfortumab Vedotin‐Related Skin Toxicities: Insights From Clinical and Histopathological Analysis. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17901

BibTeX
@article{Kuma2025,
  author = {Kuma, Yuki and Kido-Nakahara, Makiko and Kuba-Fuyuno, Yoko and Matsumoto, Takashi and Oda, Yoshinao and Eto, Masatoshi and Nakahara, Takeshi},
  title = {Enfortumab Vedotin‐Related Skin Toxicities: Insights From Clinical and Histopathological Analysis},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17901}
}
Kostenlos starten →